Logo image of HOMI.BR

HOME INVEST BELGIUM (HOMI.BR) Stock Fundamental Analysis

Europe - EBR:HOMI - BE0974409410 - REIT

18.76 EUR
-0.12 (-0.64%)
Last: 10/7/2025, 5:29:50 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to HOMI. HOMI was compared to 6 industry peers in the Residential REITs industry. While HOMI belongs to the best of the industry regarding profitability, there are concerns on its financial health. HOMI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year HOMI was profitable.
HOMI had a positive operating cash flow in the past year.
HOMI had positive earnings in 4 of the past 5 years.
HOMI had a positive operating cash flow in each of the past 5 years.
HOMI.BR Yearly Net Income VS EBIT VS OCF VS FCFHOMI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

HOMI's Return On Assets of 4.43% is amongst the best of the industry. HOMI outperforms 100.00% of its industry peers.
HOMI has a better Return On Equity (8.31%) than 100.00% of its industry peers.
The Return On Invested Capital of HOMI (2.38%) is comparable to the rest of the industry.
HOMI had an Average Return On Invested Capital over the past 3 years of 2.36%. This is in line with the industry average of 3.10%.
The 3 year average ROIC (2.36%) for HOMI is below the current ROIC(2.38%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.43%
ROE 8.31%
ROIC 2.38%
ROA(3y)4.75%
ROA(5y)4.76%
ROE(3y)9.08%
ROE(5y)9.52%
ROIC(3y)2.36%
ROIC(5y)2.27%
HOMI.BR Yearly ROA, ROE, ROICHOMI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

The Profit Margin of HOMI (109.01%) is better than 100.00% of its industry peers.
HOMI's Profit Margin has been stable in the last couple of years.
The Operating Margin of HOMI (76.41%) is better than 83.33% of its industry peers.
HOMI's Operating Margin has improved in the last couple of years.
HOMI's Gross Margin of 92.96% is amongst the best of the industry. HOMI outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of HOMI has remained more or less at the same level.
Industry RankSector Rank
OM 76.41%
PM (TTM) 109.01%
GM 92.96%
OM growth 3Y2.45%
OM growth 5Y3.82%
PM growth 3Y7.72%
PM growth 5Y0.13%
GM growth 3Y0.61%
GM growth 5Y0.41%
HOMI.BR Yearly Profit, Operating, Gross MarginsHOMI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HOMI is destroying value.
Compared to 1 year ago, HOMI has more shares outstanding
HOMI has more shares outstanding than it did 5 years ago.
HOMI has a better debt/assets ratio than last year.
HOMI.BR Yearly Shares OutstandingHOMI.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HOMI.BR Yearly Total Debt VS Total AssetsHOMI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.76, we must say that HOMI is in the distress zone and has some risk of bankruptcy.
HOMI has a Altman-Z score of 0.76. This is in the better half of the industry: HOMI outperforms 66.67% of its industry peers.
HOMI has a Debt/Equity ratio of 0.83. This is a neutral value indicating HOMI is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.83, HOMI is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF N/A
Altman-Z 0.76
ROIC/WACC0.47
WACC5.02%
HOMI.BR Yearly LT Debt VS Equity VS FCFHOMI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

HOMI has a Current Ratio of 0.37. This is a bad value and indicates that HOMI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of HOMI (0.37) is comparable to the rest of the industry.
A Quick Ratio of 0.37 indicates that HOMI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.37, HOMI is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.37
HOMI.BR Yearly Current Assets VS Current LiabilitesHOMI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

The earnings per share for HOMI have decreased strongly by -37.20% in the last year.
HOMI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.82% yearly.
Looking at the last year, HOMI shows a small growth in Revenue. The Revenue has grown by 2.60% in the last year.
HOMI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.71% yearly.
EPS 1Y (TTM)-37.2%
EPS 3Y11.06%
EPS 5Y3.82%
EPS Q2Q%-64.41%
Revenue 1Y (TTM)2.6%
Revenue growth 3Y9.86%
Revenue growth 5Y7.71%
Sales Q2Q%1.29%

3.2 Future

Based on estimates for the next years, HOMI will show a small growth in Earnings Per Share. The EPS will grow by 1.93% on average per year.
Based on estimates for the next years, HOMI will show a small growth in Revenue. The Revenue will grow by 3.65% on average per year.
EPS Next Y0.43%
EPS Next 2Y1.79%
EPS Next 3Y1.93%
EPS Next 5YN/A
Revenue Next Year2.62%
Revenue Next 2Y3.95%
Revenue Next 3Y3.65%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HOMI.BR Yearly Revenue VS EstimatesHOMI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
HOMI.BR Yearly EPS VS EstimatesHOMI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.38, which indicates a very decent valuation of HOMI.
Based on the Price/Earnings ratio, HOMI is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of HOMI to the average of the S&P500 Index (27.90), we can say HOMI is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 15.37, the valuation of HOMI can be described as correct.
HOMI's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. HOMI is more expensive than 66.67% of the companies in the same industry.
HOMI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.36.
Industry RankSector Rank
PE 9.38
Fwd PE 15.37
HOMI.BR Price Earnings VS Forward Price EarningsHOMI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HOMI is valued a bit more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.78
HOMI.BR Per share dataHOMI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of HOMI may justify a higher PE ratio.
PEG (NY)21.67
PEG (5Y)2.45
EPS Next 2Y1.79%
EPS Next 3Y1.93%

5

5. Dividend

5.1 Amount

HOMI has a Yearly Dividend Yield of 4.31%, which is a nice return.
HOMI's Dividend Yield is comparable with the industry average which is at 5.80.
HOMI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 4.31%

5.2 History

The dividend of HOMI decreases each year by -8.56%.
Dividend Growth(5Y)-8.56%
Div Incr Years2
Div Non Decr Years2
HOMI.BR Yearly Dividends per shareHOMI.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

HOMI pays out 50.67% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP50.67%
EPS Next 2Y1.79%
EPS Next 3Y1.93%
HOMI.BR Yearly Income VS Free CF VS DividendHOMI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M
HOMI.BR Dividend Payout.HOMI.BR Dividend Payout, showing the Payout Ratio.HOMI.BR Dividend Payout.PayoutRetained Earnings

HOME INVEST BELGIUM

EBR:HOMI (10/7/2025, 5:29:50 PM)

18.76

-0.12 (-0.64%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)09-03 2025-09-03
Earnings (Next)11-13 2025-11-13
Inst Owners3.1%
Inst Owner ChangeN/A
Ins Owners3.23%
Ins Owner ChangeN/A
Market Cap378.95M
Analysts45.45
Price Target21.42 (14.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.31%
Yearly Dividend0.58
Dividend Growth(5Y)-8.56%
DP50.67%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.14%
EPS NY rev (3m)-1.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.67%
Revenue NY rev (3m)-2.75%
Valuation
Industry RankSector Rank
PE 9.38
Fwd PE 15.37
P/S 10.31
P/FCF N/A
P/OCF 16.81
P/B 0.79
P/tB 0.79
EV/EBITDA 27.78
EPS(TTM)2
EY10.66%
EPS(NY)1.22
Fwd EY6.51%
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)1.12
OCFY5.95%
SpS1.82
BVpS23.86
TBVpS23.84
PEG (NY)21.67
PEG (5Y)2.45
Profitability
Industry RankSector Rank
ROA 4.43%
ROE 8.31%
ROCE 3.17%
ROIC 2.38%
ROICexc 2.39%
ROICexgc 2.39%
OM 76.41%
PM (TTM) 109.01%
GM 92.96%
FCFM N/A
ROA(3y)4.75%
ROA(5y)4.76%
ROE(3y)9.08%
ROE(5y)9.52%
ROIC(3y)2.36%
ROIC(5y)2.27%
ROICexc(3y)2.37%
ROICexc(5y)2.29%
ROICexgc(3y)2.37%
ROICexgc(5y)2.29%
ROCE(3y)3.14%
ROCE(5y)3.03%
ROICexcg growth 3Y3.18%
ROICexcg growth 5Y3%
ROICexc growth 3Y3.18%
ROICexc growth 5Y3%
OM growth 3Y2.45%
OM growth 5Y3.82%
PM growth 3Y7.72%
PM growth 5Y0.13%
GM growth 3Y0.61%
GM growth 5Y0.41%
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF N/A
Debt/EBITDA 14.11
Cap/Depr 17221.4%
Cap/Sales 87.66%
Interest Coverage 2.44
Cash Conversion 79.78%
Profit Quality N/A
Current Ratio 0.37
Quick Ratio 0.37
Altman-Z 0.76
F-Score3
WACC5.02%
ROIC/WACC0.47
Cap/Depr(3y)6185.6%
Cap/Depr(5y)5158.09%
Cap/Sales(3y)33.41%
Cap/Sales(5y)31.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.2%
EPS 3Y11.06%
EPS 5Y3.82%
EPS Q2Q%-64.41%
EPS Next Y0.43%
EPS Next 2Y1.79%
EPS Next 3Y1.93%
EPS Next 5YN/A
Revenue 1Y (TTM)2.6%
Revenue growth 3Y9.86%
Revenue growth 5Y7.71%
Sales Q2Q%1.29%
Revenue Next Year2.62%
Revenue Next 2Y3.95%
Revenue Next 3Y3.65%
Revenue Next 5YN/A
EBIT growth 1Y4.88%
EBIT growth 3Y12.55%
EBIT growth 5Y11.82%
EBIT Next Year-45.58%
EBIT Next 3Y-15.54%
EBIT Next 5YN/A
FCF growth 1Y-140.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.31%
OCF growth 3Y5.42%
OCF growth 5Y7.98%